Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
-4.85%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$346M
Cap. Flow %
-2.17%
Top 10 Hldgs %
35.77%
Holding
1,458
New
33
Increased
733
Reduced
273
Closed
36

Sector Composition

1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ORIC icon
1251
Oric Pharmaceuticals
ORIC
$1.06B
$1K ﹤0.01%
135
PAHC icon
1252
Phibro Animal Health
PAHC
$1.6B
$1K ﹤0.01%
38
AMTI
1253
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$1K ﹤0.01%
132
ICPT
1254
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1K ﹤0.01%
62
EVLO
1255
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$1K ﹤0.01%
8
JNCE
1256
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1K ﹤0.01%
75
PRVB
1257
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1K ﹤0.01%
106
ABUS icon
1258
Arbutus Biopharma
ABUS
$805M
$1K ﹤0.01%
395
ACIU icon
1259
AC Immune
ACIU
$229M
$1K ﹤0.01%
158
ADMA icon
1260
ADMA Biologics
ADMA
$4.03B
$1K ﹤0.01%
+586
New +$1K
ALLK
1261
DELISTED
Allakos
ALLK
$1K ﹤0.01%
158
ALT icon
1262
Altimmune
ALT
$334M
$1K ﹤0.01%
136
ANAB icon
1263
AnaptysBio
ANAB
$613M
$1K ﹤0.01%
60
ATHA icon
1264
Athira Pharma
ATHA
$15.4M
$1K ﹤0.01%
109
AVDL
1265
Avadel Pharmaceuticals
AVDL
$1.53B
$1K ﹤0.01%
120
JBIO
1266
Jade Biosciences, Inc. Common Stock
JBIO
$254M
$1K ﹤0.01%
+2
New +$1K
BCAB icon
1267
BioAtla
BCAB
$31.5M
$1K ﹤0.01%
103
BLUE
1268
DELISTED
bluebird bio
BLUE
$1K ﹤0.01%
12
CGEM icon
1269
Cullinan Oncology
CGEM
$413M
$1K ﹤0.01%
127
CGEN icon
1270
Compugen
CGEN
$134M
$1K ﹤0.01%
156
CMPS
1271
Compass Pathways
CMPS
$493M
$1K ﹤0.01%
64
COGT icon
1272
Cogent Biosciences
COGT
$1.82B
$1K ﹤0.01%
116
CRIS icon
1273
Curis
CRIS
$21M
$1K ﹤0.01%
13
DTIL icon
1274
Precision BioSciences
DTIL
$59.8M
$1K ﹤0.01%
7
DYN icon
1275
Dyne Therapeutics
DYN
$2.02B
$1K ﹤0.01%
150